The Uractiv portfolio acquired by Terapia includes 12 products and generates annually revenue of almost $8.7 million, in line with Cegedim data, as quoted by Sun Pharma.
Uractiv is one of the most renowned ranges of food supplements, including minerals, vitamins, cosmetics and medical devices used for the urinary tract health. The products are for both children and adults.
The acquisition is pending regulatory approvals and the financial aspects of the transaction are confidential, Sun Pharma also said in its announcement.
Fiterman Pharma, owned by the Fiterman Family from Iasi, ended 2020 with a turnover of RON189 million (EUR39 million), up 36% from 2019, as per calculations by Ziarul Financiar (ZF) daily based on public data from the finance ministry. The company’s shareholders are Solomon Fiterman (43.6%), Mara Fiterman (27.9%), Dan Fiterman (13.8%) and Patricia Fiterman (13.8%), in line with data on confidas.ro platform.